Headlines > All Processing News
Nektar abandons UK operations
02-Aug-2006 - Nektar Therapeutics has closed its processing plant in Bradford, UK as it shifts its focus to developing its own drug products using its own drug delivery technology.
PerkinElmer acquisitions expands maternal diagnostics arm
01-Aug-2006 - PerkinElmer has announced the acquisition of Macri Technologies and NTL Laboratories in a deal that means the Health Sciences and Photonics company take charge of a novel screening test for first-trimester prenatal risk assessment.
Overcoming bottlenecks in the manufacturing of biologics
01-Aug-2006 - Most pharmaceutical companies know little about how to make biopharmaceuticals on a large scale and so they need to develop in-house expertise as well as outsource several steps in their production chain, advises the head of chemistry and production at Genzyme Pharmaceuticals.
New paper demonstrates power of laboratory mass spectrometers
27-Jul-2006 - Mass spectroscopy as an analytical laboratory technique proved it's worth again recently after Cerno Bioscience and Wyeth Pharmaceuticals jointly produced a paper that demonstrates the high mass accuracy that can be achieved using triple quadrupole mass spectrometers.
Omnia Biologics seals TB vaccine production deal
26-Jul-2006 - Omnia Biologics has sealed a deal to help the Aeras Global TB Vaccine Foundation in its quest to make quantities of a new TB Vaccine that will "fulfil all the needs of the developing world."
New white paper assists labs to maintain standards
25-Jul-2006 - A new white paper has been made available to laboratories worldwide, which aims to minimise the risk of infection through focused biosafety reviews and further reinforce the required level of infection control.
Rentschler steps up contract antibody capacity
24-Jul-2006 - Rentschler Biotechnologie has heralded the start of a €50m expansion to increase its capacity to produce antibodies and mammalian cell culture-derived proteins on a commercial scale.
First vaccine for deadly ricin toxin moves closer
24-Jul-2006 - Dor BioPharma has reached the first stage in manufacturing what could be the world's first vaccine for the deadly ricin toxin.
FDA warning letter reveals neglect at Watson's plant
20-Jul-2006 - As it consolidates its manufacturing operations in the US, Watson Pharmaceuticals has received a warning letter from the US Food and Drug Administration (FDA) accusing it of using the wrong ingredients in the production of capsules, failing to prevent contamination and botching testing procedures.
Garden of Eden begins biomanufacturing bloom
20-Jul-2006 - Momentum is growing at the UK's new National Biomanufacturing Centre (NBC) as its operator Eden Biodesign inked a second contract at the centre - set up to establish England's Northwest as one of the top biomanufacturing hubs in Europe.
Prostate cancer double discovery for EU researchers
20-Jul-2006 - European researchers have not only devised a new diagnostic lab tool for prostate cancer but have also identified a new molecular marker that makes the identification of the disease much quicker.
New non-invasive monitor for disposable bioreactors
19-Jul-2006 - A new non-invasive optical method of monitoring oxygen concentration and pH levels in disposable bioreactors is now available from UK firm Cellexus Biosystems.
Hard times for Wyeth's manufacturing operations
19-Jul-2006 - With its manufacturing practices in Puerto Rico censured and marketing approval of its new oral contraceptive delayed because of its packaging, Wyeth has announced a plan to address its manufacturing issues but cautions there is no quick fix to its woes.
Bio-Rad and IDT in deal to develop RNAi tools
18-Jul-2006 - Bio-Rad Labs and Integrated DNA Technologies (IDT), have announced a collaboration to develop RNA interference (RNAi) tools sets for life science researchers.
Syntaxin bags 1.2m bioprocessing grant
18-Jul-2006 - Newly formed UK biopharma firm Synexin has bagged a £1.2m (€0.9m) bioprocessing grant as part of a nationwide push to excel in the emerging field of biopharmaceuticals.
Lab instrumentation firm takeover makes PharmEng wiser
18-Jul-2006 - Looking to expand its laboratory testing and consulting services, PharmEng has acquired Rootlink Tecknic, a laboratory instrumentation automated solution sales and service company based in Toronto.
Malvern buys NIR chemical imaging firm
13-Jul-2006 - Malvern Instruments has acquired Spectral Dimensions, a provider of near infrared (NIR) chemical imaging instrumentation and software, seeking products that can enhance pharmaceutical formulation and manufacturing processes.
PANalytical introduces slick approach to oil analysis
13-Jul-2006 - Analytical X-ray specialists, PANalytical has launched its solution to enables X-ray fluorescence (XRF) analysis of fuel, oil and oil derivatives. The package attempts to overcome the traditional challenges associated with XRF analysis of oils while keeping costs low.
MedImmune cleared to offer Flumist the reverse genetics treatment
13-Jul-2006 - In a landmark decision that will speed up the manufacturing of influenza vaccines, the US Food and Drug Administration (FDA) has approved the use of reverse genetics technology in the production of MedImmune's seasonal intranasal vaccine Flumist and its refrigerator-safe version, CAIV-T, allowing them to be the first on the market using this technique.
Isopak unveils new tablet check weigher
12-Jul-2006 - Isopak is flaunting a new automatic check weigher for capsules and tablets, promising more accuracy than ever before.
End in sight for Discovery's manufacturing nightmare?
12-Jul-2006 - Discovery Laboratories is claiming progress in its struggle to correct manufacturing problems related to Surfaxin, its experimental respiratory treatment for infants, yet the goal of overcoming the process validation issues that prevent it from having the drug approved in the US seems as distant as ever.
Cardinal joins Roche's 'bird flu crew'
12-Jul-2006 - Cardinal Health is the latest firm to benefit from Roche's global recruitment drive for manufacturers to help boost its supplies of the bird flu drug coveted by governments across the world - Tamiflu.
New lab-based kit offers superior drug response prediction
11-Jul-2006 - A recent paper has emerged, which details results of a clinical laboratory test and its ability to accurately predict drug response in lung cancer. The test gives way to the possibility of less invasive testing.
New manufacturing process can double HIV vaccine production
11-Jul-2006 - The Immune Response Corporation (IRC) claims it has developed a cell culture medium that can double viral antigen yields in HIV vaccine development.
Althea Technologies inks DNA bird flu vaccine deal
11-Jul-2006 - UK firm PowderMed has contracted US firm Althea Technologies to manufacture clinical supplies of its flu vaccine that can significantly speed up production.
Processing: Most Popular News
Spotlight
  ICH sends Q11 guidelines to EU, US & Japanese regulatorsThe ICH has sent its Q11 guidelines on APIs to regulatory bodies in the US, European Union... |
  in-Pharmatechnologist.com's review of Interphex 2012in-Pharmatechnologist.com was at Interphex 2012 in New York, US to launch the revamped version of our website and speak... |
 Effective controls still lacking for continuous processing says Interphex panelContinuous processing is still hamstrung by a lack of control systems and is not ready for specific... |
 BASF buys omega-3 maker Equateq citing pharma potentialBASF has bought omega-3 fatty acid maker Equateq, citing its pharmaceutical and dietary supplements businesses as key... |
 EMA outlines manufacturing quality docs for biologics trialsThe EMA has published final guidelines on manufacturing quality documents needed for biologics entering clinical trials. |